Sethuraman Natarajan

Entrada Therapeutics, Inc. ยท President

Sethuraman Natarajan is listed in public filings as officer: President, Research & Develop.. This Sethuraman Natarajan insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Entrada Therapeutics, Inc. (TRDA). Investors use Sethuraman Natarajan's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Entrada Therapeutics, Inc.TRDA$3.3M216.3k sharesSellMay 4, 2026$398.8K25.9k shares$15.39--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Entrada Therapeutics, Inc.TRDA$2.8M242.2k sharesGrant / ExerciseMar 3, 2026$89.1K7.6k shares$11.76--
Entrada Therapeutics, Inc.TRDA$2.9M249.8k sharesGrant / ExerciseMar 2, 2026$45.4K3.9k shares$11.66--
Entrada Therapeutics, Inc.TRDA$993k83.2k sharesGrant / ExerciseMar 1, 2026$992.6K83.2k shares$11.93--
Entrada Therapeutics, Inc.TRDA--253.7k sharesGrant / ExerciseMar 1, 2026Disclosure amount unavailable55.8k shares----
Entrada Therapeutics, Inc.TRDA$1.1M197.9k sharesGrant / ExerciseSep 2, 2025$9.6K1.8k shares$5.43--
Entrada Therapeutics, Inc.TRDA$2.3M199.7k sharesGrant / ExerciseMar 3, 2025$71.7K6.1k shares$11.68--
Entrada Therapeutics, Inc.TRDA$1.1M90.8k sharesGrant / ExerciseMar 1, 2025$1.1M90.8k shares$11.94--
Entrada Therapeutics, Inc.TRDA--205.8k sharesGrant / ExerciseMar 1, 2025Disclosure amount unavailable60.8k shares----
Entrada Therapeutics, Inc.TRDA$2.9M145k sharesSellDec 3, 2024$235.8K11.7k shares$20.15--
Entrada Therapeutics, Inc.TRDA$3.2M156.7k sharesSellDec 2, 2024$82.8K4.1k shares$20.26--
Entrada Therapeutics, Inc.TRDA$3.2M160.8k sharesSellNov 29, 2024$2.0K100 shares$20.00--
Entrada Therapeutics, Inc.TRDA$3.2M160.9k sharesSellNov 13, 2024$54.1K2.7k shares$20.04--
Entrada Therapeutics, Inc.TRDA$3.3M163.6k sharesSellNov 11, 2024$28.2K1.4k shares$20.01--
Entrada Therapeutics, Inc.TRDA$3.1M167.7k sharesSellNov 6, 2024$178.8K9.6k shares$18.71--
Entrada Therapeutics, Inc.TRDA$3.2M165k sharesSellNov 6, 2024$53.0K2.7k shares$19.32--
Entrada Therapeutics, Inc.TRDA$3.2M177.3k sharesSellNov 5, 2024$94.0K5.2k shares$18.18--
Entrada Therapeutics, Inc.TRDA$3.3M182.5k sharesSellNov 4, 2024$13.5K749 shares$18.02--
Entrada Therapeutics, Inc.TRDA$3.3M183.2k sharesSellOct 16, 2024$10.8K600 shares$18.00--
Entrada Therapeutics, Inc.TRDA$2.8M183.8k sharesSellSep 9, 2024$39.9K2.6k shares$15.09--
Entrada Therapeutics, Inc.TRDA$2.8M186.5k sharesSellSep 6, 2024$9.1K600 shares$15.24--
Entrada Therapeutics, Inc.TRDA$2.8M187.1k sharesGrant / ExerciseSep 5, 2024$2.5K167 shares$15.13--
Entrada Therapeutics, Inc.TRDA$2.9M187.2k sharesGrant / ExerciseSep 4, 2024$14.7K955 shares$15.42--
Entrada Therapeutics, Inc.TRDA$3.2M188.2k sharesGrant / ExerciseSep 3, 2024$2.6K151 shares$16.93--
Entrada Therapeutics, Inc.TRDA$3.3M188.2k sharesGrant / ExerciseSep 3, 2024$24814 shares$17.70--
Entrada Therapeutics, Inc.TRDA$3.0M188.3k sharesGrant / ExerciseSep 3, 2024$7.4K469 shares$15.76--
Entrada Therapeutics, Inc.TRDA$3.4M188.8k sharesSellJul 15, 2024$11.5K638 shares$18.00--
Entrada Therapeutics, Inc.TRDA$3.4M189.5k sharesSellJul 12, 2024$10.8K600 shares$18.00--